Literature DB >> 32896799

iSAY (incentives for South African youth): Stated preferences of young people living with HIV.

Omar Galárraga1, Caroline Kuo2, Bulelwa Mtukushe3, Brendan Maughan-Brown3, Abigail Harrison2, Jackie Hoare3.   

Abstract

High adherence to antiretroviral therapy (ART) is essential for achieving viral suppression and preventing HIV transmission. Yet adherence is suboptimal among adolescents who face unique adherence challenges. Little is known about the role of conditional economic incentives (CEIs) for increasing ART adherence in this population. During 2017-2019, we conducted a mixed-methods discrete choice experiment in Cape Town, South Africa to inform the optimal design of a CEI intervention for ART adherence among youth. In-depth interviews were conducted with n = 35 adolescents (10-19 years old) living with HIV and prescribed ART, to identify attributes of a youth-centered CEI intervention for ART adherence. A discrete choice experiment was subsequently conducted with N = 168 adolescents to elicit preferences for intervention components. A rank-ordered mixed logit model was used for main results; marginal willingness-to-accept (mWTA) was then estimated. Five attributes emerged from the qualitative research as important for a CEI-based intervention for youth ART adherence: (1) incentive amount, (2) incentive format, (3) incentive recipient, (4) delivery mode, and (5) program participants. Youth had a high probability of acceptance of any incentives program (88-100%), yet they did not have a strong preference of a quarterly over a monthly program. From a maximum incentive amount of R1920 (~US$115), youth were willing to forgo up to R126 per year (~US$9) if the incentive was given in cash (versus fashion vouchers); R274 (~US$19.6) if it was open to both previously adherent and non-adherent youth (instead of non-adherent only); and up to R91 (~US$6.5) to receive incentives at a clinic setting (instead of electronically). The use of incentives over the short term during the critical age- and developmental-transition, when adolescents begin to take sole responsibility for their medication-taking behaviors, holds great promise for habituating adherence into adulthood.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiretroviral therapy adherence; Conditional economic incentives; Discrete choice experiment; HIV; Mixed methods; Patient preferences; South Africa; Young people

Year:  2020        PMID: 32896799      PMCID: PMC7738405          DOI: 10.1016/j.socscimed.2020.113333

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  51 in total

1.  Adolescents let sufficient evidence accumulate before making a decision when large incentives are at stake.

Authors:  Theresa Teslovich; Martijn Mulder; Nicholas T Franklin; Erika J Ruberry; Alex Millner; Leah H Somerville; Patrick Simen; Sarah Durston; B J Casey
Journal:  Dev Sci       Date:  2013-09-16

2.  HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable.

Authors:  Robert W Eisinger; Carl W Dieffenbach; Anthony S Fauci
Journal:  JAMA       Date:  2019-02-05       Impact factor: 56.272

3.  Using decision mapping to inform the development of a stated choice survey to elicit youth preferences for sexual and reproductive health and HIV services in rural Malawi.

Authors:  Christine Michaels-Igbokwe; Mylene Lagarde; John Cairns; Fern Terris-Prestholt
Journal:  Soc Sci Med       Date:  2014-01-22       Impact factor: 4.634

4.  Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report.

Authors:  Ashley L Buchanan; Grace Montepiedra; Patricia A Sirois; Betsy Kammerer; Patricia A Garvie; Deborah S Storm; Sharon L Nichols
Journal:  Pediatrics       Date:  2012-04-16       Impact factor: 7.124

5.  Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations.

Authors:  Joanna Coast; Hareth Al-Janabi; Eileen J Sutton; Susan A Horrocks; A Jane Vosper; Dawn R Swancutt; Terry N Flynn
Journal:  Health Econ       Date:  2011-05-06       Impact factor: 3.046

6.  Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening.

Authors:  Esther W de Bekker-Grob; Lieke Hol; Bas Donkers; Leonie van Dam; J Dik F Habbema; Monique E van Leerdam; Ernst J Kuipers; Marie-Louise Essink-Bot; Ewout W Steyerberg
Journal:  Value Health       Date:  2009-11-12       Impact factor: 5.725

Review 7.  Changing health behaviors using financial incentives: a review from behavioral economics.

Authors:  Ivo Vlaev; Dominic King; Ara Darzi; Paul Dolan
Journal:  BMC Public Health       Date:  2019-08-07       Impact factor: 3.295

8.  The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa.

Authors:  Matthew Quaife; Peter Vickerman; Shanthi Manian; Robyn Eakle; Maria A Cabrera-Escobar; Sinead Delany-Moretlwe; Fern Terris-Prestholt
Journal:  Health Econ       Date:  2018-06-21       Impact factor: 3.046

9.  Cash incentives versus defaults for HIV testing: A randomized clinical trial.

Authors:  Juan Carlos C Montoy; William H Dow; Beth C Kaplan
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

10.  A study of financial incentives to reduce plasma HIV RNA among patients in care.

Authors:  Steven Farber; Janet Tate; Cyndi Frank; David Ardito; Michael Kozal; Amy C Justice; R Scott Braithwaite
Journal:  AIDS Behav       Date:  2013-09
View more
  7 in total

1.  Preferences for Conditional Economic Incentives to Improve Pre-exposure Prophylaxis Adherence: A Discrete Choice Experiment Among Male Sex Workers in Mexico.

Authors:  Aarón Salinas-Rodríguez; Sandra G Sosa-Rubí; Carlos Chivardi; Roxana Rodríguez-Franco; Monica Gandhi; Kenneth H Mayer; Don Operario; Nathalie Gras-Allain; Galileo Vargas-Guadarrama; Omar Galárraga
Journal:  AIDS Behav       Date:  2021-08-27

2.  Conditional Economic Incentives for HIV Treatment Adherence: Aligning Adolescent Developmental Hallmarks with Behavioral Economic Theory to Improve HIV Treatment Adherence.

Authors:  Teresa DeAtley; Abigail Harrison; Bulelwa Mtukushe; Brendan Maughan-Brown; Rudzani Muloiwa; Jackie Hoare; Omar Galárraga; Caroline Kuo
Journal:  AIDS Patient Care STDS       Date:  2022-07       Impact factor: 5.944

Review 3.  Methods for Conducting Stated Preference Research with Children and Adolescents in Health: A Scoping Review of the Application of Discrete Choice Experiments.

Authors:  Christine Michaels-Igbokwe; Gillian R Currie; Bryanne L Kennedy; Karen V MacDonald; Deborah A Marshall
Journal:  Patient       Date:  2021-05-19       Impact factor: 3.883

Review 4.  Behavioral Theories and Motivational Features Underlying eHealth Interventions for Adolescent Antiretroviral Adherence: Systematic Review.

Authors:  Alemitu Mequanint Bezabih; Kathrin Gerling; Workeabeba Abebe; Vero Vanden Abeele
Journal:  JMIR Mhealth Uhealth       Date:  2021-12-10       Impact factor: 4.773

Review 5.  Interventions to Improve Treatment Outcomes among Adolescents on Antiretroviral Therapy with Unsuppressed Viral Loads: A Systematic Review.

Authors:  Farai Kevin Munyayi; Brian van Wyk; Yolanda Mayman
Journal:  Int J Environ Res Public Health       Date:  2022-03-25       Impact factor: 3.390

6.  Adolescent and young adult preferences for financial incentives to support adherence to antiretroviral therapy in Kenya: a mixed methods study.

Authors:  Ingrid Eshun-Wilson; Eliud Akama; Fridah Adhiambo; Zachary Kwena; Bertha Oketch; Sarah Obatsa; Sarah Iguna; Jayne L Kulzer; James Nyanga; Everlyne Nyandieka; Ally Scheve; Elvin H Geng; Elizabeth A Bukusi; Lisa Abuogi
Journal:  J Int AIDS Soc       Date:  2022-09       Impact factor: 6.707

7.  "The Money, It's OK but It's not OK": Patients' and Providers' Perceptions of the Acceptability of Cash Incentives for HIV Treatment Initiation in Cape Town, South Africa.

Authors:  Alison Swartz; Brendan Maughan-Brown; Shehani Perera; Abigail Harrison; Caroline Kuo; Mark N Lurie; Philip Smith; Linda-Gail Bekker; Omar Galárraga
Journal:  AIDS Behav       Date:  2021-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.